83 related articles for article (PubMed ID: 24025158)
21. Six-transmembrane epithelial antigen of the prostate 1 is associated with tumor invasion and migration in endometrial carcinomas.
Sun J; Ji G; Xie J; Jiao Z; Zhang H; Chen J
J Cell Biochem; 2019 Jul; 120(7):11172-11189. PubMed ID: 30714206
[TBL] [Abstract][Full Text] [Related]
22. Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo.
Yuan Y; Liu Y; Zhu XM; Hu J; Zhao CY; Jiang F
J Ultrasound Med; 2019 Feb; 38(2):299-305. PubMed ID: 30027616
[TBL] [Abstract][Full Text] [Related]
23. Six-Transmembrane Epithelial Antigen of Prostate 1 (STEAP1) Has a Single b Heme and Is Capable of Reducing Metal Ion Complexes and Oxygen.
Kim K; Mitra S; Wu G; Berka V; Song J; Yu Y; Poget S; Wang DN; Tsai AL; Zhou M
Biochemistry; 2016 Dec; 55(48):6673-6684. PubMed ID: 27792302
[TBL] [Abstract][Full Text] [Related]
24. Expression of STEAP1 and STEAP1B in prostate cell lines, and the putative regulation of STEAP1 by post-transcriptional and post-translational mechanisms.
Gomes IM; Santos CR; Maia CJ
Genes Cancer; 2014 Mar; 5(3-4):142-51. PubMed ID: 25053991
[TBL] [Abstract][Full Text] [Related]
25. Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer.
Jones LA; Conway GE; Nguyen-Chi A; Burnell S; Jenkins GJ; Conlan RS; Doak SH
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):179-187. PubMed ID: 37329528
[TBL] [Abstract][Full Text] [Related]
26. Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer.
Danila DC; Szmulewitz RZ; Vaishampayan U; Higano CS; Baron AD; Gilbert HN; Brunstein F; Milojic-Blair M; Wang B; Kabbarah O; Mamounas M; Fine BM; Maslyar DJ; Ungewickell A; Scher HI
J Clin Oncol; 2019 Dec; 37(36):3518-3527. PubMed ID: 31689155
[TBL] [Abstract][Full Text] [Related]
27. A novel prognostic signature and therapy guidance for hepatocellular carcinoma based on STEAP family.
Fu D; Zhang X; Zhou Y; Hu S
BMC Med Genomics; 2024 Jan; 17(1):16. PubMed ID: 38191397
[TBL] [Abstract][Full Text] [Related]
28. Targeting STEAP1 as an anticancer strategy.
Nakamura H; Arihara Y; Takada K
Front Oncol; 2023; 13():1285661. PubMed ID: 37909017
[TBL] [Abstract][Full Text] [Related]
29. STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel.
Rocha SM; Nascimento D; Coelho RS; Cardoso AM; Passarinha LA; Socorro S; Maia CJ
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047621
[TBL] [Abstract][Full Text] [Related]
30. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy.
Bhatia V; Kamat NV; Pariva TE; Wu LT; Tsao A; Sasaki K; Sun H; Javier G; Nutt S; Coleman I; Hitchcock L; Zhang A; Rudoy D; Gulati R; Patel RA; Roudier MP; True LD; Srivastava S; Morrissey CM; Haffner MC; Nelson PS; Priceman SJ; Ishihara J; Lee JK
Nat Commun; 2023 Apr; 14(1):2041. PubMed ID: 37041154
[TBL] [Abstract][Full Text] [Related]
31. Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy.
Beck C; Casey NP; Persiconi I; Moharrami NN; Sike A; Jin Y; Kyte JA
Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36830995
[TBL] [Abstract][Full Text] [Related]
32. Specific Six-Transmembrane Epithelial Antigen of the Prostate 1 Capture with Gellan Gum Microspheres: Design, Optimization and Integration.
Batista-Silva J; Gomes D; Barroca-Ferreira J; Gallardo E; Sousa Â; Passarinha LA
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768273
[TBL] [Abstract][Full Text] [Related]
33. STEAP1 regulation and its influence modulating the response of LNCaP prostate cancer cells to bicalutamide, enzalutamide and apalutamide.
Rocha SM; Nascimento D; Cardoso AM; Passarinha L; Socorro S; Maia CJ
Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36660947
[TBL] [Abstract][Full Text] [Related]
34. STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer.
Xu M; Evans L; Bizzaro CL; Quaglia F; Verrillo CE; Li L; Stieglmaier J; Schiewer MJ; Languino LR; Kelly WK
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011027
[TBL] [Abstract][Full Text] [Related]
35. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.
Jin Y; Lorvik KB; Jin Y; Beck C; Sike A; Persiconi I; Kvaløy E; Saatcioglu F; Dunn C; Kyte JA
Mol Ther Oncolytics; 2022 Sep; 26():189-206. PubMed ID: 35860008
[TBL] [Abstract][Full Text] [Related]
36. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
[TBL] [Abstract][Full Text] [Related]
37. Regulatory Roles of Six-Transmembrane Epithelial Antigen of the Prostate Family Members in the Occurrence and Development of Malignant Tumors.
Chen WJ; Wu HT; Li CL; Lin YK; Fang ZX; Lin WT; Liu J
Front Cell Dev Biol; 2021; 9():752426. PubMed ID: 34778263
[TBL] [Abstract][Full Text] [Related]
38. Enhanced Stability of Detergent-Free Human Native STEAP1 Protein from Neoplastic Prostate Cancer Cells upon an Innovative Isolation Procedure.
Barroca-Ferreira J; Cruz-Vicente P; Santos MFA; Rocha SM; Santos-Silva T; Maia CJ; Passarinha LA
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576175
[TBL] [Abstract][Full Text] [Related]
39. Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy.
Lin TY; Park JA; Long A; Guo HF; Cheung NV
J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34497115
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
